 Animals
"Animals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.
| Descriptor ID |
D000818
|
| MeSH Number(s) |
B01.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Animals".
Below are MeSH descriptors whose meaning is more specific than "Animals".
This graph shows the total number of publications written about "Animals" by people in this website by year, and whether "Animals" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1984 | 0 | 1 | 1 | | 1985 | 0 | 1 | 1 | | 1986 | 0 | 1 | 1 | | 1987 | 0 | 1 | 1 | | 1988 | 0 | 1 | 1 | | 1989 | 0 | 3 | 3 | | 1990 | 0 | 5 | 5 | | 1991 | 0 | 3 | 3 | | 1992 | 0 | 4 | 4 | | 1993 | 0 | 7 | 7 | | 1994 | 0 | 6 | 6 | | 1995 | 0 | 6 | 6 | | 1996 | 0 | 6 | 6 | | 1997 | 0 | 11 | 11 | | 1998 | 0 | 8 | 8 | | 1999 | 0 | 16 | 16 | | 2000 | 0 | 11 | 11 | | 2001 | 0 | 20 | 20 | | 2002 | 0 | 66 | 66 | | 2003 | 0 | 66 | 66 | | 2004 | 0 | 61 | 61 | | 2005 | 0 | 56 | 56 | | 2006 | 0 | 65 | 65 | | 2007 | 0 | 77 | 77 | | 2008 | 0 | 71 | 71 | | 2009 | 0 | 82 | 82 | | 2010 | 0 | 82 | 82 | | 2011 | 0 | 84 | 84 | | 2012 | 0 | 79 | 79 | | 2013 | 0 | 76 | 76 | | 2014 | 0 | 80 | 80 | | 2015 | 0 | 91 | 91 | | 2016 | 0 | 65 | 65 | | 2017 | 0 | 67 | 67 | | 2018 | 0 | 8 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Animals" by people in Profiles.
-
Allegaert K, Smits A, van den Anker JN. Drug evaluation studies in neonates: how to overcome the current limitations. Expert Rev Clin Pharmacol. 2018 Apr; 11(4):387-396.
-
Srinivasan P, Wu X, Basu M, Rossi C, Sandler AD. PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease. PLoS Med. 2018 01; 15(1):e1002497.
-
Jones DTW, Kieran MW, Bouffet E, Alexandrescu S, Bandopadhayay P, Bornhorst M, Ellison D, Fangusaro J, Fisher MJ, Foreman N, Fouladi M, Hargrave D, Hawkins C, Jabado N, Massimino M, Mueller S, Perilongo G, Schouten van Meeteren AYN, Tabori U, Warren K, Waanders AJ, Walker D, Weiss W, Witt O, Wright K, Zhu Y, Bowers DC, Pfister SM, Packer RJ. Pediatric low-grade gliomas: next biologically driven steps. Neuro Oncol. 2018 01 22; 20(2):160-173.
-
Capogrosso RF, Mantuano P, Uaesoontrachoon K, Cozzoli A, Giustino A, Dow T, Srinivassane S, Filipovic M, Bell C, Vandermeulen J, Massari AM, De Bellis M, Conte E, Pierno S, Camerino GM, Liantonio A, Nagaraju K, De Luca A. Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. FASEB J. 2018 02; 32(2):1025-1043.
-
Abou-Antoun TJ, Nazarian J, Ghanem A, Vukmanovic S, Sandler AD. Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance. PLoS One. 2018; 13(1):e0189711.
-
Mbanefo EC, Hsieh MH. Defining the Pathways of Urogenital Schistosomiasis-Associated Urothelial Carcinogenesis through Transgenic and Bladder Wall Egg Injection Models. Methods Mol Biol. 2018; 1655:67-76.
-
Packer RJ, Fisher MJ, Cutter G, Cole-Plourde K, Korf BR. Neurofibromatosis Clinical Trial Consortium. J Child Neurol. 2018 Jan; 33(1):82-91.
-
van Putten M, Aartsma-Rus A, Grounds MD, Kornegay JN, Mayhew A, Gillingwater TH, Takeda S, Rüegg MA, De Luca A, Nagaraju K, Willmann R. Update on Standard Operating Procedures in Preclinical Research for DMD and SMA Report of TREAT-NMD Alliance Workshop, Schiphol Airport, 26 April 2015, The Netherlands. J Neuromuscul Dis. 2018; 5(1):29-34.
-
Grant M, Bollard CM. Developing T-cell therapies for lymphoma without receptor engineering. Hematology Am Soc Hematol Educ Program. 2017 12 08; 2017(1):622-631.
-
Tang F, Zhang P, Ye P, Lazarski CA, Wu Q, Bergin IL, Bender TP, Hall MN, Cui Y, Zhang L, Jiang T, Liu Y, Zheng P. A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice. Elife. 2017 12 05; 6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|